Skip to main content

RLMD

Relmada Therapeutics, Inc.

Company with tickers: RLMD

Market Cap
$682.84M
Shares Outstanding
104,890,223
CIK
1553643
CUSIP
75955J402
13F Activity (30d)
4 filings 3 filers
Investor Relations
Investor relations

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Remaining Authorization
4,000,000 shares
as of 2014-03-10 · not restated in filings since 2014-09-09

Repurchase History

Quarter Ended Cash Spent
2026-03-31 $3,360,000